Open AccessAcute worsening of glycemic control in a patient with type 2 diabetes and non‐small cell lung cancer after administration of lorlatinib
Author(s) -
Nakano Yoshio,
MiyasatoIsoda Mai,
Gohma Iwao,
Fujisawa Tomomi
Publication year - 2022
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.5283
Subject(s) - medicine , glycemic , lung cancer , type 2 diabetes , diabetes mellitus , administration (probate law) , lung , cancer , intensive care medicine , endocrinology , political science , law
A patient with non‐small cell lung cancer (NSCLC) exhibited extreme hyperglycemia after lorlatinib treatment. The present case highlights the importance of glucose monitoring during lorlatinib administration and intensifying hyperglycemia treatment.